Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Pharmacological and Toxicological Methods|October 19, 2010
Characterization of cardiac repolarization in the Göttingen minipigMorten Laursen, Søren-Peter Olesen, Morten Grunnet, et al.Journal of Pharmacological and Toxicological Methods|May 28, 2011
Keeping the rhythm -- pro-arrhythmic investigations in isolated Göttingen minipig heartsMorten Laursen, Morten Grunnet, Søren-Peter Olesen, et al.Journal of Pharmacological and Toxicological Methods|March 4, 2017
Ion currents of cardiomyocytes in different regions of the Göttingen minipig heartPer Arlock, Tomas Mow, Trygve Sjöberg, et al.Drug Discovery Today|December 26, 2013
Exploratory toxicology as an integrated part of drug discovery. Part I: Why and howJorrit J Hornberg, Morten Laursen, Nina Brenden, et al.Drug Discovery Today|December 31, 2013
Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategiesJorrit J Hornberg, Morten Laursen, Nina Brenden, et al.Bioorganic & Medicinal Chemistry Letters|December 3, 2013
Discovery and optimization of Lu AF58801, a novel, selective and brain penetrant positive allosteric modulator of alpha-7 nicotinic acetylcholine receptors: attenuation of subchronic phencyclidine (PCP)-induced cognitive deficits in rats following oral administrationJørgen Eskildsen, John P Redrobe, Anette G Sams, et al.British Journal of Pharmacology|May 27, 2017
Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in ratsMorten Laursen, Lilliana Beck, Jan Kehler, et al.Cardiovascular Research|October 24, 2013
G-protein-coupled inward rectifier potassium current contributes to ventricular repolarizationBo Liang, Jakob D Nissen, Morten Laursen, et al.The European Journal of Neuroscience|June 22, 2017
A small molecule activator of Na<sub>v</sub> 1.1 channels increases fast-spiking interneuron excitability and GABAergic transmission in vitro and has anti-convulsive effects in vivoKristen Frederiksen, Dunguo Lu, Jinhui Yang, et al.Journal of Pharmacological and Toxicological Methods|September 1, 2020
Is there a role for the no observed adverse effect level in safety pharmacology?Tomas Mow, Ninette K Andersen, Nils Dragsted, et al.Pageof 1